TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/6/24 20:15 | 2/5/24 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Denyes Nancy | CA | O | GC | M.d | 0 | 0.00 | 0 | 3 | 22 | 15 | D | ||||||||||||||
2/6/23 19:03 | 2/3/23 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Denyes Nancy | CA | O | GC | M.d | 0 | 0.00 | 0 | 3 | 61 | 7 | D | ||||||||||||||
5/28/20 20:26 | 5/16/20 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Denyes Nancy | CA | O | GC | M.d | 0 | 0.00 | 0 | 1 | 48 | 3 | D | ||||||||||||||
5/28/20 20:26 | 5/20/20 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Denyes Nancy | CA | O | GC | S.d | -1 | 3.62 | 0 | 0 | -11 | 3 | D | ||||||||||||||
5/20/19 16:38 | 5/16/19 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Krueger Nancy | CA | O | GC | M.d | 0 | 0.00 | 0 | 13 | 97 | 25 | D | ||||||||||||||
5/20/19 16:38 | 5/17/19 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Krueger Nancy | CA | O | GC | S.d | -2 | 0.4501 | 0 | -5 | -16 | 25 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |